Growing older often brings aches and pains, especially in the knees, hips, and other joints that carry the body’s weight. For many people, these problems are caused by osteoarthritis, a disease that slowly destroys cartilage.
Cartilage acts like a natural cushion inside joints, allowing bones to move smoothly without friction. When cartilage breaks down, joints become painful, stiff, and swollen.
Osteoarthritis affects millions of adults worldwide and is one of the leading causes of disability among older people.
As populations age, the number of cases continues to increase. Unfortunately, current treatments mainly focus on managing symptoms rather than repairing the damage.
Pain medications, physical therapy, exercise programs, and joint replacement surgery remain the main options available to patients.
A new study from Stanford Medicine may point toward a very different future. Researchers have discovered that blocking an age-related protein allowed older mice to regrow lost cartilage and protected injured joints from developing arthritis.
The study was published in the journal Science and has attracted attention because similar benefits were also seen in human cartilage samples.
The research centers on a protein called 15-PGDH. Scientists describe this protein as a gerozyme, meaning it is linked to biological aging. Levels of the protein increase with age, and previous research suggested it may contribute to declining tissue function in several parts of the body.
Several years ago, the same research team found that blocking 15-PGDH improved muscle strength in older mice.
They also discovered that the protein influences the repair of bone, nerve, blood, and other tissues. These findings raised an important question: could the protein also affect cartilage aging?
To find out, the researchers compared cartilage from young and old mice. They found that older animals had roughly twice as much 15-PGDH in their cartilage. This suggested the protein might play a role in cartilage deterioration.
The scientists then treated older mice with a drug that blocks the protein. The results exceeded expectations. Cartilage that had become thin and damaged with age grew thicker and healthier. Detailed analysis showed that the regenerated tissue was true articular cartilage, the smooth material needed for healthy joint movement.
One of the most surprising discoveries involved how the regeneration occurred. Scientists expected stem cells to be responsible because stem cells are commonly involved in tissue repair.
Instead, existing cartilage cells appeared to change their genetic activity and behave more like youthful cells. In effect, older cartilage cells seemed to be reprogrammed rather than replaced.
The researchers also studied injuries similar to ACL tears, which commonly occur during sports such as soccer, basketball, and skiing. Even after successful surgery, many people who tear an ACL later develop osteoarthritis. In the mouse experiments, treatment with the 15-PGDH inhibitor greatly reduced the likelihood of arthritis developing after injury.
The animals receiving treatment showed healthier joints and better movement than untreated mice. These findings suggest the therapy may not only repair aging joints but also help prevent arthritis after serious injuries.
To determine whether human tissue might respond in a similar way, the team obtained cartilage samples from patients undergoing knee replacement surgery.
After exposure to the treatment, the samples showed reduced activity of genes linked to cartilage destruction and began producing new articular cartilage.
The fact that human tissue responded positively makes the findings particularly exciting. Another important advantage is that a related oral drug is already undergoing clinical testing for age-related muscle weakness.
Because researchers already have safety information from those studies, future trials focused on cartilage repair may be able to move forward more quickly.
Even so, caution is necessary. Results from mice do not always translate directly to humans. Many treatments that perform well in animal studies ultimately fail during clinical trials. Researchers still need to determine the optimal dose, long-term safety, and effectiveness in people with osteoarthritis.
The study has several strengths. It examined both age-related cartilage loss and injury-related arthritis. It also combined animal experiments with studies of human tissue. These features provide stronger support for the findings. However, the research has not yet shown whether regenerated cartilage can remain healthy for many years in living human joints.
Overall, the discovery offers genuine hope in a field where progress has often been slow. For decades, scientists have searched for ways to restore cartilage rather than simply manage pain.
If future human studies confirm these results, blocking 15-PGDH could become one of the first treatments capable of addressing the underlying causes of osteoarthritis.
Such a breakthrough could dramatically reduce suffering and potentially help many people avoid major joint replacement surgery.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
Source: Stanford Medicine.
